Kewajiban jangka dawa perusahaan: NextGen Healthcare Inc (NXGN)

Logo grafis NextGen Healthcare Inc (NXGN)

The electronic health records sector is oversaturated, and NextGen Healthcare (NXGN) is facing pressure from tech giants seeking to lure clients away from competing ecosystems. The business is based on creating cloud services for autonomous documentation, relieving medical professionals of routine tasks. Under the management of an investment fund, the brand has solidified loyalty among US clinics. The company's debt stands at 0.28, and the price trajectory shown below illustrates the asset's dynamics.

Utang jangka dawa perusahaan NextGen Healthcare Inc (NXGN): kanggo periode 04.07.2022 - 18.11.2023
Barang unggulan NextGen Healthcare, Inc.

NextGen Healthcare (NXGN) maintains a strong position due to high switching costs for clients migrating to alternative outpatient software. The company's long-term debt aggregates all credit obligations with maturities exceeding twelve months. Investors are weighing this leverage against the steady cash flow generated by a stable user base. An analysis of the company's long-term debt allows for an assessment of the business's financial stability following the fund buyout. This trend reflects the balance between ecosystem investments and the debt load.

Analisis pesaing NextGen Healthcare

Silihan lan utang jangka dawa perusahaan VEEV|DOCS - Utang jangka dawa perusahaan|HealthEquity Inc (HQY) - Kewajiban jangka dawa perusahaan|WAY: Utang jangka dawa perusahaan|Utang jangka dawa CorVel Corp. (CRVL)|PRVA (Privia Health Group) - Utang jangka dawa perusahaan|Tanggungan utang jangka dawa perusahaan HURN (huronconsultinggroup.com)|Utang jangka dawa perusahaan Certara (CERT)|Omnicell Inc - Tanggungan utang jangka dawa perusahaan|Utang jangka dawa perusahaan GDRX (GoodRx Corp)|Schrodinger Corp (SDGR) - Utang jangka dawa|PHR: Kewajiban jangka dawa perusahaan|OMDA (omadahealth.com) - Tanggungan utang jangka dawa perusahaan|EVH (Evolent Health) - Kewajiban jangka dawa perusahaan|HSTM: Gedhene kewajiban jangka dawa|DH (Definitive Healthcare Inc.) - Utang jangka dawa perusahaan|CCSI - Tanggungan jangka dawa|Utang jangka dawa perusahaan AGL|ABSI - Utang jangka dawa|Utang jangka dawa perusahaan So-Young International Inc. SY|NRC: Tanggungan utang jangka dawa perusahaan|SPOK: Kewajiban jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan OPRX (OptimizeRx Inc.)|TBRG: Utang jangka dawa perusahaan|simulations-plus.com - Silihan lan utang jangka dawa perusahaan|SOPH (Sophia Genetics) - Utang jangka dawa perusahaan|Utang jangka dawa Health Catalyst Inc. HCAT|Utang jangka dawa perusahaan CCLD|Utang jangka dawa perusahaan researchsolutions.com (RSSS)|Utang jangka dawa perusahaan DLH Holdings DLHC|OneMedNet Corp - Utang jangka dawa perusahaan|SCNX: Kewajiban jangka dawa perusahaan|Healthcare Triangle Inc - Gedhene kewajiban jangka dawa|ISPC: Utang jangka dawa perusahaan|Bullfrog AI - Silihan lan utang jangka dawa perusahaan|WORX (SCWorx Corp.) - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan msprecovery.com (MSPR)|Utang jangka dawa perusahaan ICCT|Utang jangka dawa perusahaan TRxADE HEALTH Inc (MEDS)|Utang jangka dawa perusahaan Orgenesis Corp ORGS|Silihan lan utang jangka dawa perusahaan RCM|Sharecare, Inc. - Utang jangka dawa perusahaan|Utang jangka dawa streamlinehealth.net|Syra Health (SYRA) - Utang jangka dawa perusahaan|Tanggungan utang jangka dawa perusahaan AMEH|Kewajiban jangka dawa perusahaan MODN